Scholarlink

Background <p>Heart failure is a global health burden, yet artificial intelligence (AI) screening tools for left ventricular ejection fraction (LVEF) have largely been validated in Western populations with limited data from the Middle East. We aimed to develop and validate an interpretable-first, two-stage ECG-based machine learning pipeline to screen for reduced LVEF (Stage 1) and stratify its severity (Stage 2) in a large, diverse Middle Eastern cohort.</p> Methods <p>We conducted a retrospective study of 37,233 unique patients from a quaternary-care center in the United Arab Emirates (UAE). The cohort was split into a development set (<i>n</i> = 29,108; 2015–2023) and an independent temporal validation set (<i>n</i> = 8,125; 2024–2025). Stage 1 utilized a logistic regression model to screen for any reduced LVEF (&lt; 52% in men, &lt; 54% in women). Stage 2 applied an XGBoost classifier to positive screens to grade severity as mild (LVEF 41–51% in men, 41–53% in women), moderate (30–40%), or severe (&lt; 30%).</p> Results <p>Reduced LVEF was present in 18.0% of the overall cohort (17.5% of the development set and 18.6% of the validation set. In the validation cohort, Stage 1 achieved an AUC of 0.82 (95% CI 0.81–0.83) with sensitivity 84% (95% CI 82–86%), specificity 80% (95% CI 78–81%), negative predictive value 91% (95% CI 90–93%), and positive predictive value 68% (95% CI 66–70%). Stage 2 attained 72% overall accuracy; recall for mild, moderate, and severe dysfunction was 74%, 71%, and 72%, respectively, mirroring performance in the internal test set.</p> Conclusion <p>This two-stage AI-ECG workflow provides an interpretable-first and robust method for heart failure screening in a non-Western population. With a high NPV and temporal stability, the model effectively rules out disease and triages severity, offering a scalable “ECG-first” strategy to prioritize echocardiography resources.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Development and temporal validation of a two-stage ECG-based machine learning model for LVEF screening: a Middle Eastern cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月27日

查看全文
  • Mohammed E Khalil,
  • Adam M Khalil,
  • Mo’ath Bani Ali,
  • Rami Bani Ata,
  • Abdelrahman Zamzam,
  • Mohammad Qadura

摘要

Background

Heart failure is a global health burden, yet artificial intelligence (AI) screening tools for left ventricular ejection fraction (LVEF) have largely been validated in Western populations with limited data from the Middle East. We aimed to develop and validate an interpretable-first, two-stage ECG-based machine learning pipeline to screen for reduced LVEF (Stage 1) and stratify its severity (Stage 2) in a large, diverse Middle Eastern cohort.

Methods

We conducted a retrospective study of 37,233 unique patients from a quaternary-care center in the United Arab Emirates (UAE). The cohort was split into a development set (n = 29,108; 2015–2023) and an independent temporal validation set (n = 8,125; 2024–2025). Stage 1 utilized a logistic regression model to screen for any reduced LVEF (< 52% in men, < 54% in women). Stage 2 applied an XGBoost classifier to positive screens to grade severity as mild (LVEF 41–51% in men, 41–53% in women), moderate (30–40%), or severe (< 30%).

Results

Reduced LVEF was present in 18.0% of the overall cohort (17.5% of the development set and 18.6% of the validation set. In the validation cohort, Stage 1 achieved an AUC of 0.82 (95% CI 0.81–0.83) with sensitivity 84% (95% CI 82–86%), specificity 80% (95% CI 78–81%), negative predictive value 91% (95% CI 90–93%), and positive predictive value 68% (95% CI 66–70%). Stage 2 attained 72% overall accuracy; recall for mild, moderate, and severe dysfunction was 74%, 71%, and 72%, respectively, mirroring performance in the internal test set.

Conclusion

This two-stage AI-ECG workflow provides an interpretable-first and robust method for heart failure screening in a non-Western population. With a high NPV and temporal stability, the model effectively rules out disease and triages severity, offering a scalable “ECG-first” strategy to prioritize echocardiography resources.